• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于细胞核和细胞质作为亨廷顿病发病机制亚细胞位点的体外证据。

In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.

作者信息

Hackam A S, Singaraja R, Zhang T, Gan L, Hayden M R

机构信息

Centre for Molecular Medicine and Therapeutics, 980 West 28th Avenue, Vancouver, BC, Canada V5Z 4H4 and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V5Z 4H4.

出版信息

Hum Mol Genet. 1999 Jan;8(1):25-33. doi: 10.1093/hmg/8.1.25.

DOI:10.1093/hmg/8.1.25
PMID:9887328
Abstract

A unifying feature of the CAG expansion diseases is the formation of intracellular aggregates composed of the mutant polyglutamine-expanded protein. Despite the presence of aggregates in affected patients, the precise relationship between aggregates and disease pathogenesis is unresolved. Results from in vivo and in vitro studies of mutant huntingtin have lead to the hypothesis that nuclear localization of aggregates is critical for the pathology of Huntington's disease (HD). We tested this hypothesis using a 293T cell culture model system that compared the frequency and toxicity of cytoplasmic and nuclear huntingtin aggregates. We first assessed the mode of nuclear transport of N-terminal fragments of huntingtin, and show that the predicted endogenous NLS is not functional, providing data in support of passive nuclear transport. This result suggests that proteolysis is a necessary step for nuclear entry of huntingtin. Additionally, insertion of nuclear import or export sequences into huntingtin fragments containing 548 or 151 amino acids was used to reverse the normal localization of these proteins. Changing the subcellular localization of the fragments did not influence their total aggregate frequency. There were also no significant differences in toxicity associated with the presence of nuclear compared with cytoplasmic aggregates. The findings of nuclear and cytoplasmic aggregates in affected brains, together with these in vitro data, support the nucleus and cytosol as subcellular sites for pathogenesis in HD.

摘要

CAG 重复扩增疾病的一个共同特征是由突变的多聚谷氨酰胺扩增蛋白形成细胞内聚集体。尽管在受影响的患者中存在聚集体,但聚集体与疾病发病机制之间的确切关系仍未解决。对突变型亨廷顿蛋白的体内和体外研究结果导致了这样一种假设,即聚集体的核定位对于亨廷顿病(HD)的病理学至关重要。我们使用 293T 细胞培养模型系统测试了这一假设,该系统比较了细胞质和细胞核中亨廷顿蛋白聚集体的频率和毒性。我们首先评估了亨廷顿蛋白 N 端片段的核运输模式,并表明预测的内源性核定位信号无功能,为被动核运输提供了支持数据。这一结果表明蛋白水解是亨廷顿蛋白进入细胞核的必要步骤。此外,将核输入或输出序列插入含有 548 或 151 个氨基酸的亨廷顿蛋白片段中,以逆转这些蛋白质的正常定位。改变片段的亚细胞定位并未影响其总聚集体频率。与细胞质聚集体相比,核聚集体的存在在毒性方面也没有显著差异。在受影响的大脑中发现的细胞核和细胞质聚集体,以及这些体外数据,支持细胞核和细胞质作为 HD 发病机制的亚细胞位点。

相似文献

1
In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.关于细胞核和细胞质作为亨廷顿病发病机制亚细胞位点的体外证据。
Hum Mol Genet. 1999 Jan;8(1):25-33. doi: 10.1093/hmg/8.1.25.
2
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.在细胞培养以及表达突变亨廷顿蛋白的转基因小鼠中,细胞核和细胞质作为亨廷顿病发病机制亚细胞位点的证据。
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1047-55. doi: 10.1098/rstb.1999.0457.
3
A cellular model that recapitulates major pathogenic steps of Huntington's disease.一种概括亨廷顿舞蹈症主要致病步骤的细胞模型。
Hum Mol Genet. 1998 Sep;7(9):1355-61. doi: 10.1093/hmg/7.9.1355.
4
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.谷氨酰胺重复序列扩增的亨廷顿蛋白截短型N端片段在细胞培养中形成核内和胞质聚集体。
Hum Mol Genet. 1998 May;7(5):783-90. doi: 10.1093/hmg/7.5.783.
5
Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.作用于突变型亨廷顿蛋白的蛋白酶会产生裂解产物,这些产物会以不同方式在细胞质和细胞核中形成包涵体。
Mol Cell. 2002 Aug;10(2):259-69. doi: 10.1016/s1097-2765(02)00602-0.
6
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.携带扩展型聚谷氨酰胺序列的亨廷顿蛋白N端片段的快速聚集形成。
Biochem Biophys Res Commun. 1999 Mar 16;256(2):361-6. doi: 10.1006/bbrc.1999.0337.
7
Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.突变亨廷顿蛋白的淀粉样蛋白形成:阈值、渐进性及正常多聚谷氨酰胺蛋白的募集
Somat Cell Mol Genet. 1998 Jul;24(4):217-33. doi: 10.1023/b:scam.0000007124.19463.e5.
8
Huntingtin contains a highly conserved nuclear export signal.亨廷顿蛋白含有一个高度保守的核输出信号。
Hum Mol Genet. 2003 Jun 15;12(12):1393-403. doi: 10.1093/hmg/ddg156.
9
Polyglutamine pathogenesis.多聚谷氨酰胺发病机制。
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1005-11. doi: 10.1098/rstb.1999.0452.
10
Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.N端亨廷顿蛋白的聚集取决于其谷氨酰胺重复序列的长度。
Hum Mol Genet. 1998 May;7(5):777-82. doi: 10.1093/hmg/7.5.777.

引用本文的文献

1
Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.进行性改变白质微结构在亨廷顿病的时间过程中。
Brain Behav. 2023 Apr;13(4):e2940. doi: 10.1002/brb3.2940. Epub 2023 Mar 14.
2
Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1.亨廷顿病的新兴疗法——聚焦于N端亨廷顿蛋白和亨廷顿蛋白外显子1
Biologics. 2022 Sep 30;16:141-160. doi: 10.2147/BTT.S270657. eCollection 2022.
3
The Nuclear and DNA-Associated Molecular Chaperone Network.核与 DNA 相关的分子伴侣网络。
Cold Spring Harb Perspect Biol. 2019 Oct 1;11(10):a034009. doi: 10.1101/cshperspect.a034009.
4
Protein truncation as a common denominator of human neurodegenerative foldopathies.蛋白质截短作为人类神经退行性折叠病的共同特征。
Mol Neurobiol. 2013 Dec;48(3):516-32. doi: 10.1007/s12035-013-8440-8. Epub 2013 Mar 21.
5
An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.从体外角度探讨导致突变型亨廷顿蛋白毒性的分子机制。
Cell Death Dis. 2012 Aug 30;3(8):e382. doi: 10.1038/cddis.2012.121.
6
Huntingtin fragments and SOD1 mutants form soluble oligomers in the cell.亨廷顿蛋白片段和 SOD1 突变体在细胞中形成可溶性寡聚物。
PLoS One. 2012;7(6):e40329. doi: 10.1371/journal.pone.0040329. Epub 2012 Jun 29.
7
Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.亨廷顿病与纹状体中型棘突神经元:疾病的细胞自主和非细胞自主机制。
Neurotherapeutics. 2012 Apr;9(2):270-84. doi: 10.1007/s13311-012-0112-2.
8
Nuclear accumulation of polyglutamine disease proteins and neuropathology.聚谷氨酰胺疾病蛋白的核积累与神经病理学。
Mol Brain. 2009 Jul 3;2:21. doi: 10.1186/1756-6606-2-21.
9
Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.脊髓小脑共济失调3型(SCA3)症状的表现需要ataxin-3的核定位:体内证据。
J Neurosci. 2007 Jul 11;27(28):7418-28. doi: 10.1523/JNEUROSCI.4540-06.2007.
10
Molecular pathogenesis of spinocerebellar ataxia type 6.6型脊髓小脑共济失调的分子发病机制
Neurotherapeutics. 2007 Apr;4(2):285-94. doi: 10.1016/j.nurt.2007.01.003.